![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Tandem Diabetes Care Gets CE Mark for Insulin Pump
Tandem Diabetes Care Gets CE Mark for Insulin Pump
![](https://www.fdanews.com/ext/resources/test/Device_Images6/TandemDiabetesCare_Logo.gif?t=1525128694&width=430)
April 30, 2018
A San Diego medical device company, Tandem Diabetes Care, received a CE Mark for its t:slim X2 insulin pump with Dexcom G5 mobile continuous glucose monitoring (CGM).
The device includes a large color touchscreen, watertight construction, USB connectivity and a rechargeable battery. It is the first CGM-enabled pump that lets users make treatment decisions without pricking their finger.
The company plans to launch the pump commercially in select global markets in the second half of 2018.
Upcoming Events
-
21Oct